Evaluation of the Effectiveness of BNT162b2 Primary Vaccination and Booster Dose to SARS-CoV-2 in Eliciting Stable Mucosal Immunity.

Lambiase, Alessandro; Sacchetti, Marta; Mallone, Fabiana; Tirassa, Paola; Greco, Antonio; Angeloni, Antonio; Polimeni, Antonella

Lambiase, Alessandro; Sacchetti, Marta; Mallone, Fabiana; Tirassa, Paola; Greco, Antonio; Angeloni, Antonio; Polimeni, Antonella.

Afiliación

Lambiase A; Department of Sense Organs, Sapienza University of Rome, 00161 Rome, Italy.
Sacchetti M; Department of Sense Organs, Sapienza University of Rome, 00161 Rome, Italy.
Mallone F; Department of Sense Organs, Sapienza University of Rome, 00161 Rome, Italy.
Tirassa P; Department of Biochemistry and Cell Biology, IBBC-CNR, 00185 Rome, Italy.
Greco A; Department of Sense Organs, Sapienza University of Rome, 00161 Rome, Italy.
Angeloni A; Department of Experimental Medicine, Sapienza University of Rome, 00161 Rome, Italy.
Polimeni A; Department of Oral and Maxillofacial Sciences, Sapienza University of Rome, 00161 Rome, Italy.

Biomedicines ; 10(10)2022 Sep 29.

Article en En | MEDLINE | ID: mdl-36289692

Palabras clave

RNA vaccines; SARS-CoV-2; antibodies; ocular mucosal homeostasis; ocular mucosal immunology

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Biomedicines Año: 2022 Tipo del documento: Article País de afiliación: Italia Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google